Tyson Kim
Director Ejecutivo en SYNTEKABIO, INC. .
Cargos activos de Tyson Kim
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SYNTEKABIO, INC. | Director Ejecutivo | 01/01/2015 | - |
Radexel Co. Ltd.
 Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Director Ejecutivo | - | - |
Historial de carrera de Tyson Kim
Estadísticas
Internacional
| Estados Unidos | 2 |
| Corea del Sur | 2 |
Operativa
| Chief Executive Officer | 2 |
Sectorial
| Technology Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SYNTEKABIO, INC. | Technology Services |
| Empresas privadas | 1 |
|---|---|
Radexel Co. Ltd.
Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Health Technology |
- Bolsa de valores
- Insiders
- Tyson Kim
- Experiencia
